| Identification | Back Directory | [Name]
FMOC-LYS(TNM)-OH | [CAS]
251316-95-7 | [Synonyms]
FMOC-LYS(TNM)-OH
Fmoc-L-Lys(Tnm)-OH
FMOC-LYSINE(TNM)-OH
FMOC-LYS(TNM)-OH USP/EP/BP
Fmoc-Lys(1,5-dioxaspiro[5.5]undecane-3-nitro-3-met
FMOC-LYS(1,5-DIOXASPIRO[5.5]UNDECANE-3-NITRO-3-METHOXYCARBONYL)-OH
FMOC-LYS(1,5-DIOXOSPIRO[5,5]UNDECANE-3-NITRO-3-METHOXYCARBONYL)-OH
FMOC-N-EPSILON-(TRISHYDROXYMETHYLNITROMETHANE CATALYZED WITH CYCLOHEXANONE)-L-LYSINE
N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N6-[[(3-nitro-1,5-dioxaspiro[5.5]undec-3-yl)methoxy]carbonyl]-L-lysine
L-Lysine, N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N6-[[(3-nitro-1,5-dioxaspiro[5.5]undec-3-yl)methoxy]carbonyl]-
N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-N-EPSILON-(1,5-DIOXASPIRO[5.5]UNDECANE-3-NITRO-3-METHOXYCARBONYL)-L-LYSINE | [Molecular Formula]
C32H39N3O10 | [MDL Number]
MFCD00679033 | [MOL File]
251316-95-7.mol | [Molecular Weight]
625.67 |
| Hazard Information | Back Directory | [Definition]
ChEBI: Camptothecin is a pyranoindolizinoquinoline that is pyrano[3',4':6,7]indolizino[1,2-b]quinoline which is substituted by oxo groups at positions 3 and 14, and by an ethyl group and a hydroxy group at position 4 (the S enantiomer). It has a role as an EC 5.99.1.2 (DNA topoisomerase) inhibitor, an antineoplastic agent, a genotoxin and a plant metabolite. It is a pyranoindolizinoquinoline, a tertiary alcohol, a delta-lactone and a quinoline alkaloid. |
|
|